[ Price : $8.95]
Can-Fite BioPharma has been granted an FDA fast track designation for CF102 and its use as a second line treatment for hepatocellu...[ Price : $8.95]
FDA approves an Allergan and Gedeon Richter NDA for Vraylar (cariprazine) capsules, an atypical antipsychotic for acute treatment ...[ Price : $8.95]
House Energy and Commerce Committee leaders ask President Obama to discuss Chinas role in the 2007-08 contaminated heparin scare w...[ Price : $8.95]
FDA and TG Therapeutics agree on a Special Protocol Assessment on a Phase 3 clinical trial of its TG-1101 and TGR-1202 for treatin...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on Forms FDA 3602 and 3602A, which will allow applicants to certify that they qualify ...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on agency meetings with tobacco manufacturers, etc. on their plans to research the reg...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on: Substances Generally Recognized as Safe: Notification Procedure 21 CFR 170.36 and...[ Price : $8.95]
Federal Register FDAs Pediatric Oncology Subcommittee will meet 11/19 to discuss potential pediatric development plans for two pro...